
TYK2 Inhibitors for the Management of Plaque Psoriasis: Which of Your Patients May Benefit?
This podcast will discuss the role of TYK2 in the pathogenesis of plaque psoriasis. Through this learning activity, participants will learn to assess treatment options using TYK2 inhibitors in patients with moderate to severe plaque psoriasis, examine the role of TYK2 in pathogenesis, and identify patients that may benefit from treatment with a TYK2 inhibitor.
RELEASED DATE: December 03, 2024
EXPIRATION DATE: January 15, 2026



